Effects of actinomycin D on purine ribonucleotide metabolism in Ehrlich ascites tumor cells in vitro.
D000225:Adenine / Q000378:metabolism; D000818:Animals; D002250:Carbon Radioisotopes; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology*; D003630:Daunorubicin / Q000494:pharmacology; D007042:Hypoxanthines / Q000378:metabolism; D007292:Inosine Nucleotides; D007658:Ketone Oxidoreductases / Q000378:metabolism; D051379:Mice; D010428:Pentosephosphates; D010430:Pentosyltransferases / Q000378:metabolism; D010756:Phosphoric Acids; D011685:Purine Nucleotides / Q000378:metabolism*; D012313:RNA / Q000096:biosynthesis; D012265:Ribonucleotides / Q000378:metabolism; D013997:Time Factors
D002250:Carbon Radioisotopes; D007042:Hypoxanthines; D007292:Inosine Nucleotides; D010428:Pentosephosphates; D010756:Phosphoric Acids; D011685:Purine Nucleotides; D012265:Ribonucleotides; D003609:Dactinomycin; D012313:RNA; D007658:Ketone Oxidoreductases; D010430:Pentosyltransferases; D000225:Adenine; D003630:Daunorubicin